Search research articles
Contact Us
Filters
Showing results (71-80 of 124) with videos related to
Page
of 13
Sort By:
Annals of Hematology
|
November 13, 2008
The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma
Deok-Hwan Yang, Jung-Joon Min, Yong Yeon Jeong, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 21, 2011
Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer
Jong-Ryool Oh, Byung-Hyun Byun, Sun-Pyo Hong, et al.
Nuclear Medicine and Molecular Imaging
|
December 21, 2016
Iodine Uptake Patterns on Post-ablation Whole Body Scans are Related to Elevated Serum Thyroglobulin Levels After Radioactive Iodine Therapy in Patients with Papillary Thyroid Carcinoma
Geum-Cheol Jeong, Minchul Song, Hee Jeong Park, et al.
Nuclear Medicine Communications
|
May 20, 2020
Combined role of lymph node ratio and serum thyroglobulin levels in predicting prognosis of papillary thyroid carcinoma
Subin Jeon, Seong Young Kwon, Young Jae Ryu, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 5, 2013
Extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer
Jong-Ryool Oh, Ji-Hyoung Seo, Chae Moon Hong, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
May 26, 2021
Determination of [N-13]-ammonia extraction fraction in patients with coronary artery disease by calibration to invasive coronary and fractional flow reserve
Jonathon A Nye, Marina Piccinelli, Doyeon Hwang, et al.
Nuclear Medicine and Molecular Imaging
|
June 7, 2021
Change of Therapeutic Response Classification According to Recombinant Human Thyrotropin-Stimulated Thyroglobulin Measured at Different Time Points in Papillary Thyroid Carcinoma
Jang Bae Moon, Subin Jeon, Ki Seong Park, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 17, 2017
<sup>64</sup>Cu-Labeled Repebody Molecules for Imaging of Epidermal Growth Factor Receptor-Expressing Tumors
Ayoung Pyo, Misun Yun, Hyeon Sik Kim, et al.
Nuclear Medicine and Molecular Imaging
|
August 25, 2020
Clinical Impact of F-18 FDG PET-CT on Biopsy Site Selection in Patients with Suspected Bone Metastasis of Unknown Primary Site
Su Woong Yoo, Md Sunny Anam Chowdhury, Subin Jeon, et al.
Nuclear Medicine and Molecular Imaging
|
September 24, 2015
Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With Papillary Thyroid Carcinoma
Hee Jeong Park, Geum-Cheol Jeong, Seong Young Kwon, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 124) with videos related to
Sort By:
Page
of 13
Annals of Hematology
|
November 13, 2008
The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma
Deok-Hwan Yang, Jung-Joon Min, Yong Yeon Jeong, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 21, 2011
Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer
Jong-Ryool Oh, Byung-Hyun Byun, Sun-Pyo Hong, et al.
Nuclear Medicine and Molecular Imaging
|
December 21, 2016
Iodine Uptake Patterns on Post-ablation Whole Body Scans are Related to Elevated Serum Thyroglobulin Levels After Radioactive Iodine Therapy in Patients with Papillary Thyroid Carcinoma
Geum-Cheol Jeong, Minchul Song, Hee Jeong Park, et al.
Nuclear Medicine Communications
|
May 20, 2020
Combined role of lymph node ratio and serum thyroglobulin levels in predicting prognosis of papillary thyroid carcinoma
Subin Jeon, Seong Young Kwon, Young Jae Ryu, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 5, 2013
Extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer
Jong-Ryool Oh, Ji-Hyoung Seo, Chae Moon Hong, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
May 26, 2021
Determination of [N-13]-ammonia extraction fraction in patients with coronary artery disease by calibration to invasive coronary and fractional flow reserve
Jonathon A Nye, Marina Piccinelli, Doyeon Hwang, et al.
Nuclear Medicine and Molecular Imaging
|
June 7, 2021
Change of Therapeutic Response Classification According to Recombinant Human Thyrotropin-Stimulated Thyroglobulin Measured at Different Time Points in Papillary Thyroid Carcinoma
Jang Bae Moon, Subin Jeon, Ki Seong Park, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 17, 2017
<sup>64</sup>Cu-Labeled Repebody Molecules for Imaging of Epidermal Growth Factor Receptor-Expressing Tumors
Ayoung Pyo, Misun Yun, Hyeon Sik Kim, et al.
Nuclear Medicine and Molecular Imaging
|
August 25, 2020
Clinical Impact of F-18 FDG PET-CT on Biopsy Site Selection in Patients with Suspected Bone Metastasis of Unknown Primary Site
Su Woong Yoo, Md Sunny Anam Chowdhury, Subin Jeon, et al.
Nuclear Medicine and Molecular Imaging
|
September 24, 2015
Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With Papillary Thyroid Carcinoma
Hee Jeong Park, Geum-Cheol Jeong, Seong Young Kwon, et al.
Page
of 13